OMECAMTIV MECARBIL TABLET

Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core,...

Full description

Saved in:
Bibliographic Details
Main Authors KIANG, Yuan-Hon, BI, Mingda, LOU, Hao
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core, the film coating comprising a modified-release polymer and a pore former. Also provided is a process for making a tablet formulation and a method of treating cardiovascular conditions, such as heart failure, using the tablet formulation.
Bibliography:Application Number: US202117798531